Dr. Scott M. Rocklage is Chairman at Cidara Therapeutics, Inc., Chairman at Novira Therapeutics, Inc., Founding Partner at 5AM Venture Management LLC, Chairman at Expansion Therapeutics, Inc., Chairman at Kinestral Technologies, Inc., Managing Member at 5AM Partners II LLC and Managing Member at 5AM Partners III LLC.
He is on the Board of Directors at Aprea Therapeutics AB and Rennovia, Inc.
Dr. Rocklage was previously employed as Chief Executive Officer & Independent Director by EPIRUS Biopharmaceuticals, Inc., an Independent Director by Zalicus, Inc., Executive Chairman by Relypsa, Inc., an Independent Director by Achaogen, Inc., Chairman & Chief Executive Officer by Cubist Pharmaceuticals LLC, President & Chief Executive Officer by Nycomed Salutar, Inc., Executive Chairman & President by Ilypsa, Inc., Executive Chairman by Miikana Therapeutics, Inc., and Executive Chairman by Semprus BioSciences Corp.
He also served on the board at Pulmatrix, Inc., Pulmatrix Operating Co., Inc., EPIRUS Biopharmaceuticals, Inc. /Old/, Variation Biotechnologies (US), Inc., VBI Vaccines, Inc. and WaveRx, Inc.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Massachusetts Institute of Technology.